$12.32
0.453.79%
In chiusura: -
$12.28
-0.04-0.32%
After hour: 7:00 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Ocular Therapeutix. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Ocular Therapeutix.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Ocular Therapeutix Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno giugno 3, 2025, Nadia Waheed, l'azienda CHIEF MEDICAL OFFICER sold 13.86K condivisioni per $8.05 ciascuna.
Statistiche sulla proprietà per Ocular Therapeutix Inc
Numero di azioni emesse
173.995M
Azioni possedute dagli insider
8.291M
Percentuale posseduta dagli Insider
5.21%
Azioni possedute dagli investitori istituzionali
56.386M
Percentuale posseduta dagli investitori istituzionali
32.6%
Jun 03, 2025 | CHIEF MEDICAL OFFICER | -13.86K | $8.05 | -$111.58K | SELL | -6.28% | 206.81K | Jun 02 | ||
May 27, 2025 | CHIEF STRATEGY OFFICER | -1.86K | $7.17 | -$13.35K | SELL | -0.66% | 281.62K | May 23 | ||
May 27, 2025 | CHIEF DEVELOPMENT OFFICER | -2.97K | $7.17 | -$21.32K | SELL | -1.42% | 207.10K | May 23 | ||
May 27, 2025 | CHIEF SCIENTIFIC OFFICER | -3.02K | $7.18 | -$21.71K | SELL | -1.14% | 262.97K | May 23 | ||
May 27, 2025 | SEE REMARKS | -21.22K | $7.18 | -$152.35K | SELL | -0.60% | 3.50M | May 23 | ||
May 12, 2025 | DIRECTOR | 10.00K | $6.96 | $69.60K | BUY | 6.15% | 172.70K | May 08 | ||
Feb 26, 2025 | SEE REMARKS | -21.48K | $6.87 | -$147.53K | SELL | -0.61% | 3.52M | Feb 24 | ||
Feb 26, 2025 | CHIEF SCIENTIFIC OFFICER | -3.06K | $6.87 | -$21.03K | SELL | -1.14% | 266.00K | Feb 24 | ||
Feb 26, 2025 | CHIEF DEVELOPMENT OFFICER | -3.01K | $6.87 | -$20.67K | SELL | -1.41% | 210.08K | Feb 24 | ||
Feb 26, 2025 | CHIEF STRATEGY OFFICER | -1.90K | $6.84 | -$12.96K | SELL | -0.66% | 283.49K | Feb 24 | ||
Feb 04, 2025 | SEE REMARKS | -17.42K | $7.82 | -$136.24K | SELL | -8.26% | 193.44K | Jan 31 - Feb 04 | ||
Nov 27, 2024 | CHIEF SCIENTIFIC OFFICER | -2.95K | $9.01 | -$26.56K | SELL | -1.08% | 269.06K | Nov 25 | ||
Nov 27, 2024 | CHIEF DEVELOPMENT OFFICER | -2.90K | $9.01 | -$26.10K | SELL | -1.34% | 213.09K | Nov 25 | ||
Nov 27, 2024 | CHIEF STRATEGY OFFICER | -1.81K | $9.00 | -$16.33K | SELL | -1.03% | 174.38K | Nov 25 | ||
Nov 27, 2024 | SEE REMARKS | -20.68K | $9.01 | -$186.33K | SELL | -2.55% | 791.79K | Nov 25 | ||
Aug 27, 2024 | CHIEF STRATEGY OFFICER | -1.83K | $9.02 | -$16.52K | SELL | -1.03% | 176.19K | Aug 23 | ||
Aug 27, 2024 | SEE REMARKS | -20.88K | $9.02 | -$188.34K | SELL | -2.51% | 812.47K | Aug 23 | ||
May 28, 2024 | CHIEF STRATEGY OFFICER | -2.27K | $5.84 | -$13.28K | SELL | -1.26% | 178.03K | May 23 | ||
May 28, 2024 | SEE REMARKS | -21.63K | $5.79 | -$125.21K | SELL | -2.53% | 833.35K | May 23 | ||
Feb 27, 2024 | — | 930.85K | $7.52 | $7.00M | BUY | 12.15% | 8.59M | Feb 26 | ||
Feb 06, 2024 | CHIEF BUSINESS OFFICER | 45.89K | $4.86 | $28.72K | GRANT | 58.99% | 123.69K | Feb 03 - Feb 05 | ||
Feb 06, 2024 | GENERAL COUNSEL | 64.33K | $4.86 | $29.30K | GRANT | 66.21% | 161.49K | Feb 03 - Feb 05 | ||
Feb 06, 2024 | CHIEF MEDICAL OFFICER | 72.98K | $4.86 | $30.84K | GRANT | 91.14% | 153.05K | Feb 03 - Feb 05 | ||
Feb 06, 2024 | CHIEF FINANCIAL OFFICER | 67.85K | $4.86 | $30.19K | GRANT | 53.21% | 195.36K | Feb 03 - Feb 05 | ||
Feb 06, 2024 | PRESIDENT AND CEO | 200.04K | $4.86 | $95.46K | GRANT | 50.62% | 595.20K | Feb 03 - Feb 05 | ||
Feb 02, 2024 | CHIEF FINANCIAL OFFICER | -6.43K | $4.95 | -$31.84K | SELL | -4.40% | 139.93K | Jan 31 | ||
Feb 02, 2024 | CHIEF MEDICAL OFFICER | -7.76K | $4.95 | -$38.43K | SELL | -7.72% | 92.77K | Jan 31 | ||
Feb 02, 2024 | GENERAL COUNSEL | -6.83K | $4.95 | -$33.81K | SELL | -5.89% | 109.22K | Jan 31 | ||
Feb 02, 2024 | CHIEF BUSINESS OFFICER | -5.15K | $4.95 | -$25.48K | SELL | -5.43% | 89.62K | Jan 31 | ||
Feb 02, 2024 | PRESIDENT AND CEO | -18.34K | $4.95 | -$90.77K | SELL | -4.05% | 434.44K | Jan 31 | ||
Dec 18, 2023 | — | 1.54M | $3.25 | $5.00M | BUY | 25.13% | 7.66M | Dec 14 | ||
Sep 05, 2023 | PRESIDENT AND CEO | 6.50K | $3.81 | $24.77K | BUY | 1.46% | 452.78K | Aug 30 | ||
Jul 11, 2023 | CHIEF MEDICAL OFFICER | -832.00 | $4.93 | -$4.10K | SELL | -0.82% | 100.53K | Jul 07 | ||
Feb 08, 2023 | CHIEF BUSINESS OFFICER | -5.83K | $4.24 | -$24.71K | SELL | -5.79% | 94.77K | Feb 06 | ||
Feb 08, 2023 | CHIEF MEDICAL OFFICER | -6.42K | $4.24 | -$27.20K | SELL | -5.95% | 101.36K | Feb 06 | ||
Feb 08, 2023 | CHIEF FINANCIAL OFFICER | -6.48K | $4.24 | -$27.46K | SELL | -4.44% | 139.39K | Feb 06 | ||
Feb 08, 2023 | GENERAL COUNSEL | -6.18K | $4.24 | -$26.21K | SELL | -5.36% | 109.07K | Feb 06 | ||
Feb 08, 2023 | PRESIDENT AND CEO | -19.67K | $4.24 | -$83.40K | SELL | -4.22% | 446.28K | Feb 06 | ||
Nov 09, 2022 | 10% OWNER | 7.33K | $3.50 | $25.65K | BUY | 0.12% | 6.12M | Nov 07 | ||
Oct 12, 2022 | 10% OWNER | 20.00K | $3.95 | $78.97K | BUY | 0.33% | 6.11M | Oct 10 - Oct 11 | ||
Sep 29, 2022 | 10% OWNER | 150.00K | $4.59 | $689.23K | BUY | 2.52% | 6.09M | Sep 27 - Sep 29 | ||
May 16, 2022 | DIRECTOR | 15.00K | $3.05 | $45.75K | BUY | 62.50% | 39.00K | May 12 | ||
Feb 23, 2022 | 10% OWNER | 50.00K | $4.96 | $247.93K | BUY | 0.85% | 5.94M | Feb 18 - Feb 23 | ||
Jan 31, 2022 | 10% OWNER | 5.50K | $5.20 | $28.60K | BUY | 0.09% | 5.89M | Jan 27 - Jan 28 | ||
Jan 24, 2022 | 10% OWNER | 74.50K | $5.45 | $405.81K | BUY | 1.28% | 5.89M | Jan 20 - Jan 24 | ||
Jan 18, 2022 | 10% OWNER | 50.00K | $6.06 | $302.92K | BUY | 0.87% | 5.81M | Jan 13 - Jan 18 | ||
Dec 16, 2021 | 10% OWNER | 44.49K | $6.35 | $282.42K | BUY | 0.78% | 5.76M | Dec 14 - Dec 15 | ||
Dec 14, 2021 | 10% OWNER | 40.51K | $6.61 | $267.80K | BUY | 0.71% | 5.72M | Dec 10 - Dec 13 | ||
Dec 08, 2021 | 10% OWNER | 60.90K | $6.18 | $376.60K | BUY | 1.08% | 5.68M | Dec 06 - Dec 08 | ||
Aug 24, 2021 | PRESIDENT AND CEO | 5.00K | $9.89 | $49.45K | BUY | 5.11% | 102.90K | Aug 20 | ||
May 21, 2021 | DIRECTOR | -10.00K | $14.30 | -$143.00K | SELL | -10.00% | 90.00K | May 20 | ||
Dec 07, 2020 | — | 0.00 | $5.09 | $127.18K | OPTION EXERCISE | 0.00% | 0.00 | Dec 03 | ||
Oct 20, 2020 | — | 437.00 | $10.48 | $4.58K | PURCHASE | 0.01% | 5.62M | Oct 16 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.